|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/713 | |
| C12N 15/113 |
| (11) | Number of the document | 2723756 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12802870.1 |
| Date of filing the European patent application | 2012-06-21 | |
| (97) | Date of publication of the European application | 2014-04-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/043642 |
| Date | 2012-06-21 |
| (87) | Number | WO 2012/177947 |
| Date | 2012-12-27 |
| (30) | Number | Date | Country code |
| 201161499620 P | 2011-06-21 | US |
| (72) |
BETTENCOURT, Brian, US
FITZGERALD, Kevin, US
MILSTEIN, Stuart, US
MAIER, Martin, US
CHARISSE, Klaus, US
RAJEEV, Kallanthottathil, US
KUCHIMANCHI, Satya, US
MANOHARAN, Muthiah, US
NGUYEN, Tuyen, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES |
| COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES |